Figure 3From: Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case reportChange in AFP levels. When disease was found, the AFP level was 4,773 ng/ml. After the first treatment, the AFP level decreased to 34.4 ng/ml. The AFP level began to drop to normal after the second TACE. Since then, AFP levels have been within the normal range, as reviewed every 1 to 2 months.Back to article page